Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

The mortality rate of non-small-cell lung cancer (NSCLC) remains high worldwide. Although cisplatin-based chemotherapy may greatly enhance patient prognosis, chemotherapy resistance remains an obstacle to curing patients with NSCLC. Therefore, overcoming drug resistance is the main route to successf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Cell Dev Biol
Autori principali: Wu, Li-Mei, Liao, Xiao-Zhong, Zhang, Yan, He, Zi-Rui, Nie, Shi-Qing, Ke, Bin, Shi, Lin, Zhao, Jian-Fu, Chen, Wen-Hui
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Cell and Developmental Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892899/
https://ncbi.nlm.nih.gov/pubmed/33614623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.610097
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi